Evanston Premier Healthcare Research
Do you have acute migraines?
If so, you may qualify for a randomized, double-blind, single-dose, placebo-controlled study to assess the efficacy and safety of AXS-07 (meloxicam and rizatriptan) for the acute treatment of migraine in adults with inadequate response to prior acute treatments.
You may qualify if:
- You are male or female ages 18 to 65.
- You have a history of episodic migraine for at least 1 year.
- You have 2 to 8 migraine attacks per month.
- Inadequate response to prior acute treatments.